Article Versions Notes

Diakantonis A, Verras C, Bezati S, Bistola V, Ventoulis I, Velliou M, Boultadakis A, Ikonomidis I, Parissis JT, Polyzogopoulou E. Predictive Value of N-Terminal Pro B-Type Natriuretic Peptide for Short-Term Outcome of Cardioversion in Patients with First-Diagnosed or Paroxysmal Atrial Fibrillation Presenting to the Emergency Department. Biomedicines. 2024; 12(12):2895. https://doi.org/10.3390/biomedicines12122895

Diakantonis, Antonios, Christos Verras, Sofia Bezati, Vasiliki Bistola, Ioannis Ventoulis, Maria Velliou, Antonios Boultadakis, Ignatios Ikonomidis, John T. Parissis, and Effie Polyzogopoulou. 2024. "Predictive Value of N-Terminal Pro B-Type Natriuretic Peptide for Short-Term Outcome of Cardioversion in Patients with First-Diagnosed or Paroxysmal Atrial Fibrillation Presenting to the Emergency Department" Biomedicines 12, no. 12: 2895. https://doi.org/10.3390/biomedicines12122895

Diakantonis, A., Verras, C., Bezati, S., Bistola, V., Ventoulis, I., Velliou, M., Boultadakis, A., Ikonomidis, I., Parissis, J. T., & Polyzogopoulou, E. (2024). Predictive Value of N-Terminal Pro B-Type Natriuretic Peptide for Short-Term Outcome of Cardioversion in Patients with First-Diagnosed or Paroxysmal Atrial Fibrillation Presenting to the Emergency Department. Biomedicines, 12(12), 2895. https://doi.org/10.3390/biomedicines12122895